Published in Neuro Oncol on November 23, 2009
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer (2014) 1.10
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet (2012) 0.81
Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents. Nutr Cancer (2011) 0.79
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol (2014) 0.78
Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients. Biomed Res Int (2015) 0.78
Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis. Cancer Med (2013) 0.78
A meta-analysis of parental smoking and the risk of childhood brain tumors. PLoS One (2014) 0.77
Impact of single nucleotide polymorphism in IL-4, IL-4R genes and systemic concentration of IL-4 on the incidence of glioma in Iraqi patients. Int J Med Sci (2014) 0.76
Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis. Neural Regen Res (2013) 0.76
A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells. PLoS One (2015) 0.76
A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers. Cancer Genomics Proteomics (2016) 0.75
Characteristics of gliomas in patients with somatic IDH mosaicism. Acta Neuropathol Commun (2016) 0.75
Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history. Clin Neuropathol (2017) 0.75
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
PTEN: one gene, many syndromes. Hum Mutat (2003) 5.79
The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol (2004) 5.43
Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol (2006) 3.76
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res (2006) 3.72
Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med (1992) 2.64
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res (2005) 2.11
Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst (2001) 2.06
Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res (2007) 1.98
Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst (1994) 1.81
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70
Inherited p53 gene mutations in breast cancer. Cancer Res (1992) 1.64
Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev (2009) 1.51
Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology (1998) 1.46
GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.42
Polymorphisms of DNA repair genes and risk of glioma. Cancer Res (2004) 1.39
Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet (1995) 1.35
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis (2007) 1.30
XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol (2008) 1.30
Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res (2000) 1.27
Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat (2008) 1.26
Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev (2007) 1.22
Neurofibromatosis type 2. J Med Genet (2000) 1.22
Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res (2007) 1.22
Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies. Cancer (2007) 1.21
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet (2007) 1.19
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev (2007) 1.17
Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.17
DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology (2007) 1.15
Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene (2002) 1.15
Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. Am J Pathol (1998) 1.09
An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.09
Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma. Proc Natl Acad Sci U S A (1992) 1.08
Familiality in brain tumors. Neurology (2008) 1.06
Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? Fam Cancer (2001) 1.06
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology (2003) 1.05
The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev (2008) 1.02
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet (2007) 1.01
Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet (2007) 1.00
A novel low-penetrance locus for familial glioma at 15q23-q26.3. Cancer Res (2002) 0.99
Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology (2002) 0.99
Genetics of primary brain tumors: a review. J Neurooncol (1994) 0.98
Cancer incidence in families with multiple glioma patients. Int J Cancer (2002) 0.98
Segregation analysis of cancer in families of glioma patients. Genet Epidemiol (2001) 0.98
Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J Med Genet (2000) 0.98
Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev (2008) 0.97
Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev (2003) 0.97
Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas. Cancer Res (1997) 0.95
Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J Biol Chem (1998) 0.94
Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol (1998) 0.94
Mutagen sensitivity and risk of gliomas: a case-control analysis. Cancer Res (1996) 0.92
Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene (1997) 0.90
Analysis of p53 tumor suppressor gene in families with multiple glioma patients. J Neurooncol (2001) 0.90
Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme. Genes Chromosomes Cancer (2005) 0.89
Mutations of the p16 gene in gliomas. Oncogene (1996) 0.89
Multicentric glioblastoma multiforme in a patient with BRCA-1 invasive breast cancer. Breast J (2006) 0.88
Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas. Int J Cancer (2008) 0.88
Homozygosity mapping of familial glioma in Northern Sweden. Acta Oncol (2005) 0.87
DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis. Cancer Res (2002) 0.86
Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma. Brain Res (2006) 0.85
Absence of germline and somatic p53 alterations in children with sporadic brain tumors. J Neurooncol (2001) 0.83
Familial glioma: a report of glioblastoma in identical twins and oligo-astrocytoma in siblings. Br J Neurosurg (1989) 0.82
Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma. Clin Cancer Res (1997) 0.82
Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française. Ann Neurol (1999) 0.82
Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors. Int J Cancer (2003) 0.82
A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer (2002) 0.81
Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J Neurooncol (2007) 0.81
Cytogenetic and molecular abnormalities in astrocytic gliomas (Review). Oncol Rep (2000) 0.80
Primary glioblastomas and anaplastic astrocytoma in a glioma family. J Clin Neurosci (2006) 0.78
Risk assessment for developing gliomas: a comparison of two cytogenetic approaches. Mutat Res (2001) 0.77
Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas. Carcinogenesis (1999) 0.76
Dental x-rays and risk of meningioma. Cancer (2012) 5.99
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA (2009) 3.86
ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27
Cytogenetic effects in children treated with methylphenidate. Cancer Lett (2005) 3.05
Effects of nativity, age at migration, and acculturation on smoking among adult Houston residents of Mexican descent. Am J Public Health (2005) 2.94
Epidemiology of intracranial meningioma. Neurosurgery (2005) 2.60
Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol (2007) 2.40
Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer (2004) 2.38
RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol Chem (2005) 2.38
Birthplace, years of residence in the United States, and obesity among Mexican-American adults. Obesity (Silver Spring) (2007) 2.28
Breast cancer treatment guidelines in older women. J Clin Oncol (2005) 1.97
Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol (2008) 1.94
Association between hepatitis B virus and pancreatic cancer. J Clin Oncol (2008) 1.93
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene (2004) 1.91
Adult glioma incidence trends in the United States, 1977-2000. Cancer (2004) 1.78
Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer (2007) 1.70
Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol (2007) 1.58
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin Cancer Res (2006) 1.53
Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev (2009) 1.51
An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. Pediatr Blood Cancer (2012) 1.49
MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer (2010) 1.48
Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology (2002) 1.48
Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene (2003) 1.41
Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity. Oncotarget (2012) 1.40
Polymorphisms of DNA repair genes and risk of glioma. Cancer Res (2004) 1.39
Proteases and glioma angiogenesis. Brain Pathol (2005) 1.39
Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene (2003) 1.36
Correlates of susceptibility to smoking among Mexican origin youth residing in Houston, Texas: a cross-sectional analysis. BMC Public Health (2008) 1.36
RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene (2004) 1.35
Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol (2004) 1.35
Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway. Int J Oncol (2007) 1.34
Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer (2007) 1.33
Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis. Cancer Res (2007) 1.29
Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis (2005) 1.29
Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev (2008) 1.28
Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans. Clin Cancer Res (2010) 1.28
The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol (2015) 1.27
High levels of oxidative DNA damage in lymphocyte DNA of premenopausal breast cancer patients from Egypt. Int J Environ Health Res (2004) 1.27
MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One (2011) 1.27
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2008) 1.25
Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin Cancer Res (2008) 1.25
Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.23
RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer (2007) 1.23
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer. Oncologist (2011) 1.22
Molecular epidemiology of primary brain tumors. Neurotherapeutics (2009) 1.22
Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol (2007) 1.21
Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice. Clin Cancer Res (2007) 1.21
Exposure to smoking imagery in the movies and experimenting with cigarettes among Mexican heritage youth. Cancer Epidemiol Biomarkers Prev (2009) 1.20
Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther (2006) 1.20
Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer (2007) 1.20
Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev (2009) 1.19
Cathepsin B as a cancer target. Expert Opin Ther Targets (2013) 1.19
Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis (2010) 1.17
Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.17
Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis (2004) 1.17
siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int J Oncol (2006) 1.16
Serum organochlorine levels and history of lactation in Egypt. Environ Res (2003) 1.16
Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB. J Biol Chem (2007) 1.16
Dietary mutagen exposure and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.15
Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol (2010) 1.15
Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene (2002) 1.15
Maternal BMI and country of birth as indicators of childhood obesity in children of Mexican origin. Obesity (Silver Spring) (2007) 1.15
Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res (2004) 1.14
Assessing breast cancer risk: evolution of the Gail Model. J Natl Cancer Inst (2006) 1.13
XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol (2007) 1.13
Axonal remyelination by cord blood stem cells after spinal cord injury. J Neurotrauma (2007) 1.13
Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene (2002) 1.12
A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila) (2012) 1.11
Neuroprotection by cord blood stem cells against glutamate-induced apoptosis is mediated by Akt pathway. Neurobiol Dis (2008) 1.11
A review of body size and breast cancer risk in Hispanic and African American women. Cancer (2011) 1.09
The Childhood Leukemia International Consortium. Cancer Epidemiol (2013) 1.09
Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget (2011) 1.09
Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol (2008) 1.08
Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. Int J Cancer (2005) 1.08
Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One (2010) 1.08
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol (2006) 1.08
Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev (2006) 1.08
Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis (2002) 1.07
The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett (2006) 1.07
SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Int J Oncol (2006) 1.06
Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer (2003) 1.06
Familial aggregation of glioma: a pooled analysis. Am J Epidemiol (2010) 1.06
Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells. BMC Cancer (2010) 1.05
Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One (2010) 1.05
Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Cancer Res (2007) 1.05
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res (2005) 1.05
Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res (2007) 1.05
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene (2004) 1.05
Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells. Int J Oncol (2010) 1.04
uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Int J Oncol (2008) 1.04
RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther (2006) 1.03
Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Cancer Res (2003) 1.03
Effects of irradiation on tumor cell survival, invasion and angiogenesis. J Neurooncol (2010) 1.03
Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells. J Biol Chem (2012) 1.02
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS One (2011) 1.02
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene (2003) 1.02
Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma. PLoS One (2010) 1.02